Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995–1008

Article  PubMed  Google Scholar 

Kuwana M, Kaburaki J, Ikeda Y (1998) Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 102:1393–1402

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. https://doi.org/10.3390/jcm6020016

Article  PubMed  PubMed Central  Google Scholar 

Kelton JG, Vrbensky JR, Arnold DM (2018) How do we diagnose immune thrombocytopenia in 2018? Hematology 2018:561–567

Article  PubMed  PubMed Central  Google Scholar 

Liu B, Zhao H, Poon M-C, Han Z, Gu D, Xu M et al (2007) Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 78:139–143

Article  CAS  PubMed  Google Scholar 

Arandi N, Mirshafiey A, Jeddi-Tehrani M, Shaghaghi M, Sadeghi B, Abolhassani H et al (1970) Alteration in frequency and function of CD4+CD25+FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura. Iran J Allergy Asthma Immunol [Internet]. [cited 2019 May 3];13. Available from: http://ijaai.tums.ac.ir/index.php/ijaai/article/view/472

Talaat RM, Elmaghraby AM, Barakat SS, El-Shahat M (2014) Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Exp Immunol 176:291–300

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKenzie CGJ, Guo L, Freedman J, Semple JW (2013) Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol 163:10–23

Article  CAS  PubMed  Google Scholar 

Verschoor A, Langer HF (2013) Crosstalk between platelets and the complement system in immune protection and disease [Internet]. Vol. 110, Thrombosis and haemostasis. Thromb Haemost [cited 2020 Dec 3]. Available from: https://pubmed.ncbi.nlm.nih.gov/24008927/

Li Z, Mou W, Lu G, Cao J, He X, Pan X et al (2011) Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol 93:91–98

Article  CAS  PubMed  Google Scholar 

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393

Article  CAS  PubMed  Google Scholar 

El-Rashedi FH, El-Hawy MA, Helwa MA, Abd-Allah SS (2017) Study of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura. Hematol Oncol Stem Cell Ther 10:8–14

Article  CAS  PubMed  Google Scholar 

Xu R, Zheng Z, Ma Y, Hu Y, Zhuang S, Wei B et al (2014) Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Exp Ther Med 7:149–154

Article  CAS  PubMed  Google Scholar 

Johansson U, Macey MG, Kenny D, Provan D, Newland AC (2004) α-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment. Br J Haematol 125:400–404

Article  CAS  PubMed  Google Scholar 

Sakakura M, Wada H, Tawara I, Nobori T, Sugiyama T, Sagawa N et al (2007) Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res 120:187–193

Article  CAS  PubMed  Google Scholar 

Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N et al (2010) Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 116:4639–4645

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu Y, Wang M, Hou Y, Qin P, Zeng Q, Yu W et al (2020) High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: a prospective, multicenter, randomized trial. Am J Hematol 95:1542–1552

Article  CAS  PubMed  Google Scholar